This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.
Automatically generated on April 18, 2025.
Return to the list of Patented Medicine Litigation page.
Donepezil
ARICEPT, ARICEPT RDT – Pfizer Canada Inc. (NOC Search)
Patents:
- 1338808: EISAI, MINT, EISAI, PHARMASCIENCE, APOTEX, EISAI, EISAI, MYLAN, GENPHARM, EISAI, MYLAN, EISAI, RANBAXY, EISAI, ACTAVIS, EISAI, RATIOPHARM
- 2252806: AURO, EISAI, EISAI, MINT, ACTAVIS, EISAI, EISAI, PHARMASCIENCE, APOTEX, EISAI, SANDOZ, EISAI, ACCORD HEALTHCARE, EISAI, EISAI, EISAI, RANBAXY, GENPHARM, EISAI, MYLAN, EISAI, ACTAVIS, EISAI, RATIOPHARM
ACCORD HEALTHCARE, EISAI
- PM(NOC) – T-1032-12
ACTAVIS, EISAI
- PM(NOC) – T-119-12
APOTEX, EISAI
AURO, EISAI
- PM(NOC) – T-1033-12
EISAI
- PM(NOC) – T-414-12
EISAI, ACTAVIS
- PM(NOC) – T-120-12
EISAI, MINT
- PM(NOC) – T-12-12
EISAI, MYLAN
- Appeal – A-226-11 (2012 FCA 103)
EISAI, PHARMASCIENCE
EISAI, RANBAXY
- PM(NOC) – T-2184-10
EISAI, RATIOPHARM
- PM(NOC) – T-713-10
GENPHARM, EISAI, MYLAN
- PM(NOC) – T-1118-09 (2010 FC 684, 2011 FC 547)
SANDOZ, EISAI
- PM(NOC) – T-103-10
Return to the Patented Medicine Litigation page.